Concepedia

Ben O’Leary

BO

22

Publications

2.9K

Citations

16

H-Index

2002

Active since

Affiliations

Institute of Cancer Research(Current)

Royal Marsden Hospital

Breast Cancer Now

Pfizer (United States)

Royal Marsden NHS Foundation Trust

Ben O’Leary is an author at Institute of Cancer Research specializing in medicine, oncology, and tumor biology.

ORCID

Top concepts

Publications per year

2002–2024

22

Publications

22

Plasma <i>ESR1</i> Mutations and the Treatment of Estrogen Receptor–Positive Advanced Breast Cancer

Charlotte Fribbens, Ben O’Leary, Lucy Kilburn et al. · Journal of Clinical Oncology · 2016 · 696 citations

The Genetic Landscape and Clonal Evolution of Breast Cancer Resistance to Palbociclib plus Fulvestrant in the PALOMA-3 Trial

Ben O’Leary, Rosalind Cutts, Yuan Liu et al. · Cancer Discovery · 2018 · 642 citations · Full text

Early circulating tumor DNA dynamics and clonal selection with palbociclib and fulvestrant for breast cancer

Ben O’Leary, Sarah Hrebien, James P. Morden et al. · Nature Communications · 2018 · 404 citations · Full text

Overall Survival with Palbociclib and Fulvestrant in Women with HR+/HER2− ABC: Updated Exploratory Analyses of PALOMA-3, a Double-blind, Phase III Randomized Study

Massimo Cristofanilli, Hope S. Rugo, Seock‐Ah Im et al. · Clinical Cancer Research · 2022 · 185 citations · Full text

Tracking evolution of aromatase inhibitor resistance with circulating tumour DNA analysis in metastatic breast cancer

Charlotte Fribbens, Isaac García-Murillas, Matthew Beaney et al. · Annals of Oncology · 2017 · 153 citations · Full text

, , +15

Rows per page

1–5 of 22